Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 560

recruiting
3 983
countries
28
conditions
2 109

10 385 trials match your criteria

Pulmonary fibrosis

Not recruiting

Study on the Effects of Inhaled Treprostinil for Patients with Progressive Pulmonary Fibrosis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil

Study on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Study on the Effectiveness of Adding Progesterone to Chemotherapy with Etoposide, Doxorubicin, Cisplatin, and Mitotane for Advanced Adrenocortical Carcinoma Patients

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Megestrol acetate

Glioma

Not recruiting

Study on the Safety and Effectiveness of Sirolimus for Treating High-Grade Glioma in Children

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years

Premature baby+1

Not recruiting

Study on Budesonide and Poractant Alfa for Preventing Lung Disease in Very Preterm Infants

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years

Study on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years

Sarcoidosis

Not recruiting

Study on Long-term Safety of XTMAB-16 for Patients with Pulmonary Sarcoidosis with or without Extra-pulmonary Involvement

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years

Depression

Not recruiting

Study on Improving ECT Response and Reducing Cognitive Side Effects in Depression Patients Using Rivastigmine

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Rivastigmine

Study on the Safety and Effects of Saracatinib for Patients with Fibrodysplasia Ossificans Progressiva (FOP)

Investigational
Countries:GermanyGermany
  • Participants:18–64 years

Multiple sclerosis

Not recruiting

Study on the Safety and Effectiveness of TolDec and Immunotherapy for Patients with Relapsing-Remitting Multiple Sclerosis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years

Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years

Chronic hepatitis B

Not recruiting

Study on Stopping Tenofovir Alafenamide, Tenofovir Disoproxil, and Entecavir in Patients with Chronic Hepatitis B

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.